InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: smoki post# 4394

Wednesday, 11/21/2018 1:33:10 PM

Wednesday, November 21, 2018 1:33:10 PM

Post# of 16729
Yeah smoki. Although I got senselessly attacked yesterday, It appears I wasn't too far off in my business thoughts yesterday regarding the Mini-Me Theory @ Breathtec vs Cannabix:

The hate is real and will remain that way unless and until Kal and/or Chris finally put out some news, strategies (sustained media blitz/campaign) that will excite even the dumber than dumb potential shareholder in order to get us past the norms of the past 2 plus years.

investorshub.advfn.com/boards/read_msg.aspx?message_id=145003495

Jeff Neilson has a Multi-Part Pharma Series to Dumb Down (Due Dilligence) the message for anyone seriously interested in holding Breathtec beyond the usual flip flopping crystal ball campaign of nonsense. Were golden IF management can stick to it's black and white timelines and financial assessments without massive dilution.

What are these thirteen “needles”? What is the commercial potential of NASH’s lead R&D programs? What are other companies worth that have brought such drugs to market?

In Parts II and III of Stockhouse’s first multi-part series, investors will learn the answers to these questions and more.

www.stockhouse.com/news/newswire/2018/11/20/nash-pharmaceuticals-1-fast-tracking-pharma-success

Peace 2 All



/////AMG


P.S. For the others... enjoy your dessert


Red Pills